Source:http://linkedlifedata.com/resource/pubmed/id/17939640
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2007-10-17
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1565-1088
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
690; author reply 690-1
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17939640-Antineoplastic Agents,
pubmed-meshheading:17939640-Cardiomyopathies,
pubmed-meshheading:17939640-Dose-Response Relationship, Drug,
pubmed-meshheading:17939640-Doxorubicin,
pubmed-meshheading:17939640-Heart Failure,
pubmed-meshheading:17939640-Humans,
pubmed-meshheading:17939640-Interferons
|
pubmed:year |
2007
|
pubmed:articleTitle |
Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction?
|
pubmed:publicationType |
Letter,
Comment
|